November 18, 2026
Health news, explained with evidence
LIVE

Study reveals how pre-transplant conditioning shapes human immune system recovery

🔬 Research 2 min read 👁 6

A recent study from USC researchers demonstrates how chemotherapy and radiation regimens prior to bone marrow transplantation influence human blood and immune cell regeneration.

Study reveals how pre-transplant conditioning shapes human immune system recovery🔬Research

Photo: Medical Xpress

Key points

  • Genetic barcoding tracked human HSCs and MPPs in mice to observe immune system regeneration.
  • Different conditioning methods—radiation versus chemotherapy—altered blood cell production rates and types.
  • Human MPPs showed unexpected long-term regenerative capacity compared to earlier animal-based assumptions.

Researchers at the USC Stem Cell lab investigated how human blood-forming stem and progenitor cells rebuild the immune system following a bone marrow transplant. Published in npj Regenerative Medicine and led by Rong Lu, Ph.D., the study utilized genetic barcoding to track individual human cells after transplanting them into mice. The team evaluated two specific cell populations: hematopoietic stem cells (HSCs) and multipotent progenitor cells (MPPs).

Cell behavior and conditioning impacts

The investigation examined how these cell types respond to different pretransplant conditioning methods, which prepare a patient's body by clearing space for donor cells. Mice received either radiation, chemotherapy using busulfan, or no conditioning treatment. While overall donor cell engraftment remained stable, the conditioning approach directly influenced the speed of recovery and the types of blood cells produced. Notably, HSCs maintained relatively consistent production across different environments, whereas MPPs showed higher sensitivity to conditioning, altering the types of immune cells they generated.

Furthermore, the findings suggest that human MPPs may possess greater long-term regenerative potential than previously indicated by animal models, though HSCs remained superior at producing multiple blood cell lineages over time. Experts note that because this research relied on animal models, additional clinical investigations are necessary to confirm how these mechanisms translate directly to human patients undergoing therapy for conditions like leukemia, lymphoma, and inherited blood disorders.

What to know: Pretransplant conditioning methods shape the recovery of human blood and immune cells differently depending on the cell type involved, offering potential pathways for personalized treatment regimens. Readers should consult a qualified healthcare provider for guidance regarding personal medical decisions and treatments.

Source Medical Xpress — medicalxpress.com/news/2026-11-chemotherapy-bone-marrow-transplantation… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.